NasdaqGS - Delayed Quote • USD
Anavex Life Sciences Corp. (AVXL)
At close: 4:00 PM EDT
After hours: 6:39 PM EDT
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 2 | 2 | 2 | 2 |
| Avg. Estimate | -0.11 | -0.12 | -0.48 | -0.64 |
| Low Estimate | -0.13 | -0.15 | -0.57 | -0.87 |
| High Estimate | -0.09 | -0.09 | -0.39 | -0.41 |
| Year Ago EPS | -0.17 | -0.14 | -0.6 | -0.48 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 2 | 2 | 2 | 2 |
| Avg. Estimate | -- | -- | -- | -- |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | -- |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | -- | -- | -- | -- |
Earnings History
| CURRENCY IN USD | 3/31/2023 | 6/30/2023 | 9/30/2023 | 12/31/2023 |
|---|---|---|---|---|
| EPS Est. | -0.19 | -0.17 | -0.15 | -0.14 |
| EPS Actual | -0.17 | -0.14 | -0.12 | -0.11 |
| Difference | 0.02 | 0.03 | 0.03 | 0.03 |
| Surprise % | 10.50% | 17.60% | 20.00% | 21.40% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | -0.11 | -0.12 | -0.48 | -0.64 |
| 7 Days Ago | -0.11 | -0.12 | -0.48 | -0.64 |
| 30 Days Ago | -0.11 | -0.12 | -0.48 | -0.64 |
| 60 Days Ago | -0.11 | -0.12 | -0.48 | -0.64 |
| 90 Days Ago | -0.15 | -0.17 | -0.54 | -0.31 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | AVXL | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | 35.30% | -- | -- | 1.50% |
| Next Qtr. | 14.30% | -- | -- | 11.40% |
| Current Year | 20.00% | -- | -- | 5.20% |
| Next Year | -33.30% | -- | -- | 13.40% |
| Next 5 Years (per annum) | -- | -- | -- | 11.09% |
| Past 5 Years (per annum) | -- | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
| Maintains | HC Wainwright & Co.: Buy to Buy | 1/3/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 11/28/2023 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 8/8/2023 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 7/20/2023 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 6/29/2023 |
| Reiterates | HC Wainwright & Co.: Buy | 5/2/2023 |
Related Tickers
ANVS Annovis Bio, Inc.
12.74
+7.24%
SAVA Cassava Sciences, Inc.
20.74
+0.92%
SAVAW Cassava Sciences, Inc.
0.2201
-42.08%
INMB INmune Bio, Inc.
10.62
+4.73%
AXSM Axsome Therapeutics, Inc.
71.17
-2.61%
ALT Altimmune, Inc.
7.08
-6.47%
NWBO Northwest Biotherapeutics, Inc.
0.4601
-2.54%
TGTX TG Therapeutics, Inc.
13.98
-1.89%
SAGE Sage Therapeutics, Inc.
14.00
+8.11%
IOVA Iovance Biotherapeutics, Inc.
11.71
-1.26%